Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Mouse Model of Tuberculosis: Uses and Abuses.

Cold Spring Harbor perspectives in medicine·2026
Same author

Alveolar macrophages shape tuberculosis susceptibility by delaying protective immunity.

Mucosal immunology·2026
Same author

First impressions count in TB.

The Journal of experimental medicine·2025
Same author

Branched-Chain Amino Acids Exacerbate Colitis Progression by Lowering Colonic Fumarate Levels.

Inflammatory bowel diseases·2025
Same author

Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis.

PLoS pathogens·2024
Same author

Evolutionary origin and population diversity of a cryptic hybrid pathogen.

Nature communications·2024

Related Experiment Video

Updated: Jun 6, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

IL-17 and Th17 cells in tuberculosis.

Egídio Torrado1, Andrea M Cooper

  • 1Trudeau Institute, Inc., 154 Algonquin Ave., Saranac Lake, NY 12983, USA.

Cytokine & Growth Factor Reviews
|November 16, 2010
PubMed
Summary

Tuberculosis control requires balancing immune responses in the lungs. Regulating interferon-gamma (IFN-γ) and interleukin-17 (IL-17) is crucial to fight Mycobacterium tuberculosis and prevent tissue damage.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pulmonology

Background:

  • Tuberculosis (TB) primarily affects the lungs, necessitating continuous cellular immunity to control Mycobacterium tuberculosis.
  • Chronic inflammation and pathology can arise from persistent immune responses in the lung.
  • Both IFN-γ and IL-17 are induced during primary TB, driving inflammation and granuloma formation.

Purpose of the Study:

  • To investigate the critical role of immune response regulation in tuberculosis.
  • To understand the balance between Th1 (IFN-γ) and Th17 (IL-17) responses in controlling Mycobacterium tuberculosis and preventing immunopathology.

Main Methods:

  • This study focuses on the immunological mechanisms during tuberculosis infection.
  • Analysis of cytokine profiles, specifically Interferon-gamma (IFN-γ) and Interleukin-17 (IL-17), in the context of Mycobacterium tuberculosis infection.

More Related Videos

In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse
07:46

In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse

Published on: October 25, 2024

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells
12:38

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells

Published on: December 18, 2008

Related Experiment Videos

Last Updated: Jun 6, 2026

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes
12:59

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse
07:46

In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse

Published on: October 25, 2024

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells
12:38

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells

Published on: December 18, 2008

Main Results:

  • During primary TB, both IFN-γ and IL-17 are induced, promoting inflammation and granuloma organization.
  • A balance between Th1 and Th17 responses is essential during chronic TB to control bacterial growth and limit tissue damage.
  • Excessive IL-17 production can lead to neutrophil recruitment and significant tissue damage.

Conclusions:

  • Regulation of Th1 and Th17 immune responses is vital for effective anti-mycobacterial immunity.
  • Maintaining a balance between these T-helper cell responses is key to preventing severe immunopathological consequences in tuberculosis.
  • Immune modulation strategies targeting Th1/Th17 balance may offer therapeutic potential for TB.